AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

MICONAZOLE + HYDROCORTISONE

9 registrations across 5 African markets— 8 active

Markets with MICONAZOLE + HYDROCORTISONE

Recent registrations

Brand / ProductMarketHolderStatusExpires
DAKTACORT 2% CREAM ( Miconazole/ Hydrocortisone 2%w/w/ 1%w/w)🇬🇭GhanaactiveJun 2027
DAKTACORT 2% CREAM ( Miconazole/ Hydrocortisone 2%w/w/ 1%w/w)🇬🇭GhanaactiveJun 2027
MICORT COMBINATION PRODUCT CREAM
CREAM
🇲🇼MalawiexpiredMar 2025
MICONAZOLE + HYDROCORTISONE
TOPICAL EXTERNAL CREAMS
🇺🇬UgandaXEPA-SOUL PATTINSONactive
MICONAZOLE + HYDROCORTISONE
TOPICAL EXTERNAL CREAMS
🇺🇬UgandaXEPA-SOUL PATTINSONactive
Micort
Cream
🇹🇿TanzaniaVarichem Pharmaceuticals Private Limitedactive
MICONAZOLE + HYDROCORTISONE
TOPICAL EXTERNAL CREAMS
🇺🇬UgandaXEPA-SOUL PATTINSONactive
MICONAZOLE + HYDROCORTISONE
TOPICAL EXTERNAL CREAMS
🇺🇬UgandaXEPA-SOUL PATTINSONactive
MICONAZ – H EMULGEL TOPIQUE 2 % / 1 %, TUBE DE 20 G🇨🇮Côte d'IvoireLABORATOIRES MEDICAL UNION PHARMACEUTICALSactive

MICONAZOLE + HYDROCORTISONE in Africa — Regulatory Overview

MICONAZOLE + HYDROCORTISONE is registered across 5 African markets with 9 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Uganda, Ghana, Côte d'Ivoire, Malawi and 1 more. AfricaRegulatory refreshes this data daily from official government sources.

Of the 9 registrations, 8 (89%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.